Down-regulation of TERE1/UBIAD1 activated Ras-MAPK signalling and induced cell proliferation

Yanzhi Xia1, Xiong Wei, Shimin Wu

  • 1College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, Peoples Republic of China ; †Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Peoples Republic of China.

Insights

Decreased TERE1/UBIAD1 expression activates Ras-MAPK signaling, leading to increased cell proliferation in human cancers. This suggests TERE1/UBIAD1 acts as a tumor suppressor by negatively regulating this pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • TERE1/UBIAD1 is implicated in Schnyder crystalline corneal dystrophy and human cancers.
  • The precise molecular mechanisms of TERE1/UBIAD1 in tumorigenesis remain largely undefined.

Purpose of the Study:

  • To investigate the role of TERE1/UBIAD1 in transitional cell carcinoma (TCC) pathogenesis.
  • To elucidate the molecular pathway through which TERE1/UBIAD1 influences cancer cell proliferation.

Main Methods:

  • Quantitative analysis of TERE1/UBIAD1 and hTERT expression in Chinese TCC samples.
  • In vitro knockdown of TERE1 using chemically modified siRNA in L02 cells.
  • Assessment of Ras-MAPK pathway activation (ERK phosphorylation) and hTERT expression.
  • Pharmacological inhibition of the Ras-MAPK pathway using U0126.

Main Results:

  • Reduced TERE1/UBIAD1 expression correlated with elevated hTERT and activated Ras-MAPK signaling in TCC.
  • TERE1 knockdown in L02 cells induced significant cell proliferation, increased hTERT expression, and ERK phosphorylation.
  • MEK inhibition with U0126 reversed these effects, suppressing ERK phosphorylation and hTERT expression.

Conclusions:

  • TERE1/UBIAD1 downregulation activates the Ras-MAPK pathway, promoting cancer cell proliferation.
  • TERE1/UBIAD1 functions as a novel negative regulator of Ras-MAPK signaling.
  • TERE1/UBIAD1 represents a potential therapeutic target for cancers driven by Ras-MAPK pathway dysregulation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...